Tocqueville Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Tocqueville Asset Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-3,500	Closed	-$79K	–	1369
2014 Q2	$79K	Hold	3,500	–	–	﹤0.01%	1217
2014 Q1	$99K	Buy	+3,500	New	+$130K	﹤0.01%	930

Other funds holding DRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Tocqueville Asset Management's DRNA Position: Q3 2014 in Review

Tocqueville Asset Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2014, closing a stake of 3,500 shares — an estimated $79K sold.

Tocqueville Asset Management first reported a position in DRNA in Q1 2014 and held it in 2 quarters. The position peaked at $99K in Q1 2014. 40 funds tracked by Wall St. Rank hold DRNA as of Q3 2014.

Tocqueville Asset Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
Tocqueville Asset Management sold 3,500 Dicerna Pharmaceuticals, Inc. shares in Q3 2014, an estimated $79K.
Tocqueville Asset Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
Tocqueville Asset Management's Dicerna Pharmaceuticals, Inc. position peaked at $99K in Q1 2014.
40 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2014.

Based on Tocqueville Asset Management's 13F filing for Q3 2014, filed 30 Oct 2014.